Slider 1 We hereby declare that Temax can guarantee the flow of thermal packaging for pharmaceuticals and health products to our international customers during the COVID-19 pandemic. This guarantee is provided by our three international factories and separate warehouses where continuous stock flow and QA is provided. COVID-19 Manufacturing Stability Declaration Slider 1 Hierbij verklaren wij dat Temax de flow van thermische verpakkingen voor farmaceutica en healthcare naar onze internationale klanten kan garanderen. Deze garantie wordt geboden door onze drie internationale fabrieken en afgescheiden magazijnen waar continue voorraadstromen en QA worden verzorgd. COVID-19 Productie stabiliteitsverklaring Slider 1 Hiermit erklären wir dass Temax die Anlieferung von Thermoverpackungen für Pharmazeutika und Gesundheitsprodukte an unsere internationalen Kunden garantieren kann. Diese Garantie bieten unsere drei internationalen Produktionen und separaten Lager, in denen für kontinuierliche Warenflüsse und Qualitätssicherung gesorgt ist. Erklärung zur Produktionsstabilität Slider 1 Nous déclarons par la présente que Temax peut garantir le flux d'emballages thermiques pour les produits pharmaceutiques et de santé à nos clients internationaux. Cette garantie est fournie par nos trois usines internationales et nos entrepôts séparés où les flux de stock continus et l'assurance qualité sont pris en charge. Déclaration de stabilité de la production

Products/Supply Chain
Formulas/Recycling Formulas/Green Manufacturing

TRM-Plan Temperature Risk Management

TRM-plan "Temperature Risk Management" - guidelines on thermal blankets usage - ISBN 9789048439560

The purpose of the Krautz-TEMAX® T.R.M.-plan “Temperature Risk Management” is to offer guidelines and attention points when Temax® thermal blankets are used as a passive cooling system for the temperature protection of time-temperature sensitive pharmaceuticals in transport, storage and distribution, without the use of extra thermal energy generators (gel packs, P.C.M.’s “Phase Change Materials”, Dry-Ice, etc…). In the development of these guidelines the following G.D.P. “Good Distribution Practice” guidelines were considered for the transport of pharmaceuticals and healthcare products:

  • European Commission: G.D.P. Guidelines 05.11.2013: pharmaceuticals for human use
  • WHO “World Health Organization”: G.D.P. Guidelines 2010: Annex5 – pharmaceuticals

This T.R.M.-plan contains the written instructions on handling Temax® thermal blankets and functions as general documentation to the G.D.P. guidelines. This T.R.M.-plan functions as a master documentation and overwrites any other Temax® information.

Published ISBN – 9789048439560
Guidelines thermal blankets – 52 pages – English language
This book is available on special email request: see page contact

This book will be personally dedicated to the receiver (GDP documentation guideline)
This book is yearly re-published with up-to-date information


  1. Scope TRM-plan "Temperature Risk Management"
  2. Temax-4000 as thermal blanket
  3. T.R.P.'s Temperature Risk Procedures
  4. Supply chain of Temax insulation material
  5. S.O.P's Standard Operation Procedures
  6. Temperature measurement and validation
  7. G.M.P. Good Manufacturing Practice contribution
  8. Quality assurance and control
  9. Transport of finished products
  10. Recycling - ecological footprint - New use
  11. Training and certification
  12. Internal and external audits
  13. Notifications
  14. Worksheets
  15. Remarks and notes

Temax® applications in Pharmaceuticals
The Temax® thermal blankets are used in the airfreight cold chain logistics of time-temperature sensitive pharmaceuticals. The following pharmaceuticals and healthcare products are temperature protected with the Temax® thermal blankets according to specific configurations:

Ambient pharmaceuticals

  • Low risk pharmaceuticals (+0°C to +40°C) or (32°F to 104°F)
  • Medium risk pharmaceuticals (+2°C to +30°C) or (35°F to 86°F)
  • High risk pharmaceuticals (+15°C to +25°C) or (59°F to 77°F)

Chilled pharmaceuticals

  • High risk pharmaceuticals (+2°C to +8°C) or (35°F to 46°F)
  • Low risk pharmaceuticals

Airfreight cold chain logistics
The guidelines and attention points in this T.R.M.-plan are dedicated to airfreight cold chain logistics, yet they may also apply to other transport systems such as sea freight or road transport in which the Temax® thermal blankets are used.

Enter your keyword